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Since early 2000, there has been an exponential rise 
in the use of methamphetamine, locally called ‘tik’, 
in the Western Cape Province, South Africa (SA). 
Studies consistently show that methamphetamine 
use is associated with poor mental health, including 
depression, psychosis and suicidality.[1] In SA, research has 
demonstrated an increased risk of mental health problems among 
methamphetamine users, including aggressive behaviour[2] and 
symptoms of depression and anxiety.[3]
The relationship between methamphetamine and mental health is 
complex. On the one hand, poor mental health may be a risk factor 
for the initiation of substance use, as people may ‘self-medicate’ as a 
way to deal with psychiatric distress.[4] On the other hand, substance 
use results in numerous psychosocial sequelae, including isolation, 
family breakdown and loss of employment, which can contribute to 
mental health problems. Chronic methamphetamine use is associated 
with structural and functional changes in the brain that may account 
for the increased rate of psychiatric disturbance in this population.[5] 
Furthermore, the cycle of addiction (including intoxication, bingeing, 
withdrawal and craving) may lead to depressed mood, lethargy and 
anhedonia.
Regardless of whether psychiatric disturbances precede or 
follow the initiation of methamphetamine use, understanding the 
mental health experiences and needs of methamphetamine users 
in SA is important, as poor mental health may be a barrier to 
drug cessation and harm reduction efforts. Psychological distress 
impacts on motivation to initiate drug treatment services,[3] and 
ongoing distress may contribute to attrition from treatment. In 
addition, mental health problems may serve as barriers to reducing 
harms such as risky sexual behaviours that are associated with 
continued substance use. Despite the potential impact of untreated 
mental disorders on treatment seeking and outcomes, there has 
been little research on how methamphetamine users experience 
symptoms of psychological distress. This gap needs to be addressed 
so that appropriate intervention programmes can be developed for 
methamphetamine users in SA.
Methods
Overview
The results presented here come from a mixed-methods study that 
included a cross-sectional survey of 360 current methamphetamine 
users and in-depth interviews (IDIs) with a subset of 30 participants. 
Data collection was completed between May and October 2013 in 
Delft, a township on the Cape Flats, Western Cape.
Sample
Participants were recruited into the cross-sectional survey using 
a respondent-driven sampling strategy, described elsewhere.[6] 
Individuals were eligible to participate if they were ≥18 years old and 
positive for methamphetamine use on a urine drug screen. A subset of 
30 participants were selected to participate in IDIs to explore the study 
topics in greater depth. The IDI participants were purposefully selected 
to provide a balance of race and gender representation and to include 
individuals who the staff felt would be articulate and reflective.
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Data collection
Quantitative procedures and measures
Participants completed an audio computer-assisted self-interview, 
followed by a clinical interview. Data collection was conducted by 
trained staff in a private room. The visit took approximately 2 hours, 
and assessments were completed in the language of the participants’ 
choice (Afrikaans, Xhosa or English).
Mental health symptoms. The nine-item Patient Health Question-
naire (PHQ-9) measured frequency of depressive symptoms in the 
past 2 weeks. Scores range from 0 to 27, and a dichotomous measure 
was created for moderate depression (≥10).[7] The seven-item Breslau 
Post-Traumatic Stress Disorder (PTSD) screener was used to capture 
traumatic stress symptoms in the past month. The yes/no responses were 
summed to create composite scores ranging from 0 to 7; a recommended 
cut-off of 4 was used as an indication of PTSD symptoms.[8]
Addiction Severity Index Lite (ASI-L). The ASI-L is a semi-
structured interview for substance-abusing populations that assesses 
several different areas of functioning, including substance use and 
mental health.[9] Participants reported the number of days they had 
used methamphetamine in the past 30 days, as well as the number of 
years they had used methamphetamine regularly. They also reported 
the number of days they had experienced psychological problems in the 
past 30 days, whether they had ever experienced particular psychiatric 
symptoms, including hallucinations, suicidal ideation, suicide attempt 
and aggressive behaviour, and whether they had experienced these 
symptoms in the past 30 days. Participants were asked whether they 
had ever received treatment for psychological problems, whether they 
had ever been hospitalised for psychological problems, and whether 
they had ever been prescribed psychiatric medications. Participants 
rated how troubled they were by psychological symptoms and how 
important they perceived psychiatric treatment to be for them (with 
responses ranging from ‘not at all’ to ‘extremely’).
Substance use coping. Participants responded to the four-item 
substance use subscale of the COPE[10] to assess how often they used 
substances as a coping mechanism. Response options ranged from 
‘never or rarely’ to ‘almost always.’
Qualitative procedures
The IDIs were conducted by local interviewers with extensive 
training in qualitative methods in the language of the participant’s 
choice, and lasted approximately 60 - 90 minutes. A semistructured 
interview guide included broad opening questions and more 
specific follow-up probes. The mental health content included 
questions and probes about chronic and acute stressors, areas of 
emotional distress, distress symptoms including suicidal ideation 
and suicide attempts, coping behaviours, and any mental health 
treatment sought or received.
Ethical concerns
Given the sensitive nature of the interviews, the team received extensive 
and ongoing training by a local clinical psychologist on how to support 
participants, how and when to offer active referrals to local service 
agencies, and how to assess for risk of suicide. A list of referrals was 
provided to all participants, and the interviewer offered to make active 
referrals when participants were in distress. The psychologist was on 
call to advise staff on steps that needed to be taken with distressed 
participants. The study protocol was approved by ethical review boards 
at Stellenbosch University and Duke University.
Analysis
Analysis was conducted using a concurrent triangulation strategy, 
whereby qualitative and quantitative data contributed equally to 
the analysis and were used for cross-validation. For the quantitative 
analysis, descriptive statistics were used to characterise the mental 
health symptoms, needs and treatment-seeking behaviour of the 
sample. For the qualitative analysis, audio recordings of the interviews 
were transcribed and translated into English. Narrative memos were 
written to organise the content of the transcripts, make connections 
across the transcript content, and begin to achieve meaningful 
insights into the data. NVivo software was used to conduct content 
analysis. The quantitative and qualitative data were then combined to 
provide a full picture of the mental health experiences and needs of 
the population.
Results
The sample included 201 men and 159 women, described in Table 1. 
The 17 men and 13 women who completed IDIs had demographic 
and drug-related characteristics similar to the full sample.
Presentation of mental health symptoms
In the survey data, 49.3% of respondents met the criteria for 
moderate depression and 54.0% the screening criteria for PTSD. On 
average, individuals reported experiencing 11.7 days (range 0 - 30, 
standard deviation (SD) 12.8) of psychological problems in the past 
30 days. Almost half of the sample (47.9%) reported being ‘extremely’ 
bothered by psychological symptoms in the past month. Women 
reported more days of psychological problems than men (13.5 v. 
10.2; p<0.05). 
In the IDIs, most participants expressed psychological distress. 
Depressive symptoms included crying during the interview, 
loneliness, lethargy, and lack of interest in life. For men, feelings of 
regret and low self-worth were dominant, as this man expressed: ‘My 
mind is suffering, because I had my own plans, but none of them are 
successful.’ Several women talked about symptoms consistent with 
PTSD, typically related to histories of sexual or physical abuse. One 
woman, in recounting her sexual abuse history, said, ‘When you are 
asking me about that I just feel like vomiting … I don’t want to talk 
about my difficult memories.’
Participants spoke about the impact of methamphetamine on their 
psychological state. Several said that methamphetamine made them 
more ‘emotional’. One man stated that smoking methamphetamine 
‘puts you more in touch with your feelings. You are not 100% in control 
when it comes to thoughts or actions, but you are more emotional. 
You feel more. You sense more.’ Hallucinations and paranoia also 
seemed to be common during periods of methamphetamine use. 
When not intoxicated, people spoke about feeling extreme lethargy 
and lack of interest in life.
Methamphetamine as a coping mechanism
Using substances to cope with stressors was common, with nearly half 
of the survey sample saying that they used substances to feel better, 
lose themselves, avoid thoughts and get through difficult situations 
(Table 2). In the IDIs, participants spoke about methamphetamine 
as a ‘comfort zone’ and a way to ‘calm down’. Many reported using 
methamphetamine to numb feelings, forget disturbing memories, and 
cope with their daily lives. A woman who had severe depression and 
a history of multiple traumas said that she used methamphetamine 
to cope with her emotional symptoms: ‘The moment I increased 
my daily intake (of methamphetamine), my body felt much better. 
I could also manage emotionally.’ A man spoke about how he used 
methamphetamine to deal with daily stressors: ‘If the pressure 
gets too much, or I can’t handle things, then I have a fix. I do that 
to cut myself off from everything and not focus. I just want to be 
narrow minded.’ Five people specifically talked about initiating 
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methamphetamine for the first time as a way 
to cope with feelings or events in their lives.
Suicidality
In the survey data, 32.8% of the sample said 
that they had ever had suicidal thoughts, 
and 21.9% said that they had ever attempted 
suicide. Women were significantly more likely 
to have ever had suicidal thoughts (42.8% v. 
24.9%; p<0.001) and to have ever attempted 
suicide (33.3% v. 12.9%; p<0.001). In the IDIs, 
10 of the 30 participants recounted suicide 
attempts, with many of those individuals 
reporting multiple attempts. The reasons 
that men expressed for attempting suicide 
were feeling rejected by family as a result of 
drug use, breaking up with a girlfriend, and 
feeling in a ‘dark place’. Among women, four 
attributed their suicide attempts to traumas 
(sexual abuse, partner abuse and husband’s 
murder), and the others spoke about general 
distress and problems in relationships. The 
most common way that people attempted 
suicide was via medication overdose, followed 
by hanging and cutting. Suicidal ideation was 
also common, with participants talking about 
feeling that they would be ‘better off dead’.
Treatment-seeking behaviour 
Only 7.2% of the survey sample had ever 
received treatment for a psychological 
problem. The majority (69.2%) of those who 
reported that that they had received treatment 
said that they had been hospitalised for 
psychiatric reasons. Despite low uptake of 
mental health treatment, almost half (47.1%) 
said that receiving psychological treatment was 
‘extremely important’ to them. In the qualitative 
data, there was little discussion of mental 
health treatment. Five participants said that 
they had received some psychiatric treatment 
after being hospitalised for a suicide attempt, 
but none had follow-up after discharge. One 
woman explained that she felt that providers 
were not interested in treating drug users: 
‘After I came back from the hospital [after 
suicide attempt], they said they would check 
on me sometimes, but they never did. I told 
you before, not everyone is interested in us.’ 
Only one of the IDI participants had received 
outpatient mental health counselling, which 
she apparently received through the HIV clinic 
where she was receiving care. Notably, several 
participants spoke about the study contact as a 
therapeutic experience, indicating a desire and 
need for mental health counselling. As this 
woman explained: ‘I am feeling a great relief 
after talking to you. A heavy weight is lifted 
from my shoulders.’
Discussion
While previous studies in SA have 
documented the high prevalence of mental 
health problems among methamphetamine 
users,[2,3] none have explored how users 
understand the relationship between 
methamphetamine use and psychological 
distress. We combined quantitative and 
qualitative methods to document the mental 
health experiences and needs of out-of-
treatment methamphetamine users from one 
township in Cape Town. This study yields 
information that could potentially inform 
the development of mental health services 
for methamphetamine users in SA.
We found high rates of psychological 
distress in this population, with close to half 
of the participants scoring above the cut-off 
for depression and more than half meeting 
screening criteria for PTSD. Despite the high 
Table 1. Characteristics of the sample (N=360)
Men
(N=201)
Women
(N=159) Statistic
Demographics
Age, mean (SD) 28.92 (7.59) 29.04 (6.95) t (358) = 0.15
Race, coloured v. black African, n (%) 125 (62.2) 138 (86.8) c2(1) = 27.30**
Currently married, n (%) 22 (10.9) 28 (17.6) c2(1) = 3.30
Employed (part or full time), n (%) 46 (22.9) 21 (13.2) c2(1) = 5.49*
Completed secondary school, n (%) 22 (10.9) 20 (12.6) c2(1) = 0.23
Methamphetamine use and addiction
Years of regular use, mean (SD) 7.15 (4.04) 6.95 (3.08) t (358) = 0.52
Days of use in past 30 days, mean (SD) 24.26 (8.73) 22.52 (9.05) t (358) = 1.86
Mental health
Depression symptoms (PHQ-9 ≥10), n (%) 96 (47.8) 81 (50.9) c2(1) = 0.31
PTSD symptoms (Breslau ≥4), n (%) 107 (53.2) 88 (55.3) c2(1) = 0.11
Days of problems, past 30 days, mean (SD) 10.16 (12.17) 13.47 (13.23) t (329) = 2.37*
Felt extremely bothered by problems, n (%) 89 (44.3) 78 (49.1) c2 (1) = 0.87
Hallucinations, lifetime, n (%) 104 (51.7) 63 (39.6) c2 (1) = 5.24*
Hallucinations, past 30 days, n (%) 98 (48.8) 60 (37.7) c2(1) = 4.38*
Suicidal ideation, lifetime, n (%) 50 (24.9) 68 (42.8) c2(1) = 12.90**
Suicidal ideation, past 30 days, n (%) 26 (12.9) 25 (15.7) c2(1) = 0.57
Suicide attempt, lifetime, n (%) 26 (12.9) 53 (33.3) c2(1) = 21.56**
Suicide attempt, past 30 days, n (%) 9 (4.5) 16 (10.1) c2 (1) = 4.29*
Aggressive behaviour, lifetime, n (%) 148 (73.6) 89 (56.0) c2(1) = 12.31**
Aggressive behaviour, past 30 days, n (%) 118 (58.7) 84 (52.8) c2(1) = 1.25
 Treatment perceived as extremely 
important, n (%)
91 (45.3) 77 (48.4) c2(1) = 0.44
**p<0.01, *p<0.05.
Table 2. Frequency of substance use as a coping mechanism to deal with stressors (N=360)
Never/rarely
n (%)
Occasionally
n (%)
Often
n (%)
Almost always
n (%)
Use alcohol or drugs to feel 
better*
37 (10.3) 132 (36.7) 123 (34.2) 67 (18.6)
Try to lose myself by drinking 
or taking drugs
50 (13.9) 151 (41.9) 97 (26.9) 62 (17.2)
Drink or take drugs to think 
about it less
49 (13.6) 138 (38.3) 108 (30.0) 65 (18.1)
Use alcohol or drugs to help 
get through it
60 (16.7) 145 (40.3) 97 (26.9) 58 (16.1)
*One answer missing.
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burden of mental disorders, very few participants had ever accessed 
mental health services, indicating a large unmet need for mental health 
treatment. This is not surprising, given evidence of a 75% treatment 
gap for common mental disorders in SA.[11] Further complicating 
matters for a substance-using population, substance abuse and other 
mental health services are delivered by distinct service systems, with 
neither system equipped to address both problems effectively in an 
integrated manner,[12] although our findings indicate that a substantial 
proportion of methamphetamine users could benefit from integrated 
substance abuse and mental health services. Some might argue that 
the depressive symptomatology in this population is likely to be a 
consequence of the physiological effects of methamphetamine,[5] and 
may resolve after a period of abstinence. However, this explanation 
does not account for the high rates of PTSD observed in this sample. 
Our qualitative data suggest that traumatic experiences are likely to 
have preceded the initiation of methamphetamine use, with many 
participants reporting that they used methamphetamine as a way 
of coping with negative feelings associated with these experiences. 
For these participants, effective treatment requires addressing their 
traumatic experiences, particularly as unresolved trauma is associated 
with poor drug treatment outcomes.[13]
In addition to using methamphetamine as a way of coping 
with traumatic experiences, participants reported using metham-
phetamine to handle their everyday stressors. This is likely to be the 
result of poor problem-solving and coping skills. We also observed 
gender differences in how methamphetamine use was used to 
help people cope with stressful events. Women’s narratives suggest 
that methamphetamine is used as an avoidance strategy to block, 
numb or dull negative psychological distress. In contrast, men 
reported using methamphetamine to facilitate emotional discharge 
or catharsis, a form of emotion-focused coping. The reliance on 
these maladaptive coping styles highlights the need for interventions 
to help methamphetamine users develop more adaptive problem-
focused coping strategies.
Addressing psychological distress is particularly important in view 
of the alarmingly high rates of suicide attempts in this population. 
More than a third of women and more than 10% of men reported 
prior suicide attempts, higher than the national prevalence of 3%.[14] 
This finding provides further evidence of the need to integrate mental 
health services into existing substance abuse programmes. At the 
very least, all patients reporting methamphetamine use should be 
screened for risk of suicide, and programming for methamphetamine 
dependence should include a focus on suicide prevention.
These findings have several other implications for the prevention 
and treatment of methamphetamine use. First, universal prevention 
programmes should consider equipping young people with 
problem-focused coping skills to help delay initiation of substance 
use. Second, prevention programmes indicated for individuals who 
are using methamphetamine but are not yet dependent should 
include a focus on developing adaptive coping and problem-
solving styles, particularly given emerging evidence that brief, 
problem-solving therapies are effective for reducing substance 
use involvement in high-risk SA populations.[15] Third, as mental 
health problems and problem-solving deficits are risk factors 
for poor treatment outcomes,[15] substance abuse services should 
screen all methamphetamine users for co-occurring mental health 
problems and provide patients with coping and problem-solving 
interventions to help them deal with life stressors. Finally, the low 
use of mental health services in this population indicates a need for 
improving community awareness of mental health problems and 
resources, which may hinder uptake and consistent use of available 
community-based services.
Study strengths and limitations
While this study has several strengths, including the largest sample 
of community-recruited methamphetamine users in SA, it does have 
some limitations. First, findings may not generalise to the entire 
population of methamphetamine users or to methamphetamine 
users in other communities. Second, our sample may have been 
skewed towards regular methamphetamine users, as we only 
included participants with a positive urine screen that detects 
methamphetamine in the urine for 3 - 5 days. Although we may have 
excluded less frequent users, our results do reflect the need for mental 
health services among regular methamphetamine users. Finally, we 
did not undertake clinical interviewing to determine mental health 
diagnoses, but rather relied on symptom checklists.
Conclusion
This study clearly demonstrates that mental health services should be 
made more readily available to methamphetamine users. The high 
prevalence of suicide attempts and psychological distress in this sample 
highlights the need for evidence-based substance abuse prevention inter-
ventions that also promote mental health through developing adaptive 
coping strategies. Additionally, to improve drug treatment outcomes, 
programmes should screen methamphetamine users for suicide risk and 
psychological distress, deliver services that treat their substance use and 
underlying mental health conditions in an integrated manner, and teach 
adaptive coping strategies to prevent relapse to substance use.
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